Wednesday, November 14, 2018
Print Current Day:
|
|
SESSION 23 SCHEDULE | |
Wednesday
SESSION 23:
TOPICS RELATED TO GENERALITIES IN THE ENDOVASCULAR AND OPEN TREATMENT OF LOWER EXTREMITY OCCLUSIVE LESIONS
|
|
x | |
6:40 AM - 6:45 AM | Status Of The Global Vascular Guideline For The Treatment Of CLTI And The Global Limb Anatomic Staging System: How Will They Help |
Presenter(s):Michael S. Conte, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
6:46 AM - 6:51 AM | How Have Drug Delivery (Coating) And Retrograde Access Changed The Paradigm For SFA/Pop Treatment: The Game Has Changed |
Presenter(s):Peter A. Schneider, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
6:52 AM - 6:57 AM | The Class Effect vs. The Specific Device Effect Of Drug Eluting Devices And Other Treatments For Arterial Occlusive Lesions: Why Is The Difference Important |
Presenter(s):Thomas Zeller, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
6:58 AM - 7:03 AM | DEBATE: In The Near Future Almost All Lower Extremity Treatment For Occlusive Lesions Will Be Endovascular And Endo-First Will Be The Rule |
Presenter(s):Craig M. Walker, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
7:04 AM - 7:09 AM | DEBATE: Not So: Many Patients Will Be Better Served By A Bypass At Some Point In Their Course, And Some With A Bypass As Their Primary Procedure |
Presenter(s):Joseph L. Mills, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
7:10 AM - 7:15 AM | Overuse Of Endo-First Treatment For CLTI With Tissue Necrosis Jeopardizes Last Chance Bypasses And Limb Salvage |
Presenter(s):Jean-Baptiste Ricco, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
7:16 AM - 7:21 AM | Importance Of Adequate Vessel Prep Before Stenting And DCBs: How Best To Do It And Proof Of Its Value |
Presenter(s):D. Christopher Metzger, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
7:22 AM - 7:27 AM | Value Of Local Anesthesia In The Adventia Of Arteries During Interventions: How To Do It: For SFA/Pop Lesions |
Presenter(s):Andrej Schmidt, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
7:28 AM - 7:33 AM | Optimal Current Treatment For SFA/Pop Occlusive Lesions: What Technology Is Best And When |
Presenter(s):Gary M. Ansel, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
7:34 AM - 7:39 AM | Below The Ankle (BTA) PTA: When Is It Helpful: When Harmful: Should 1 Or More Arteries Be Treated; Other Pearls |
Presenter(s):Roberto Ferraresi, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
7:40 AM - 7:46 AM | Panel Discussion |
END OF SESSION 23 | |
SESSION 24 SCHEDULE | |
Wednesday
SESSION 24:
PROGRESS IN LOWER EXTREMITY STENT BASED TREATMENTS FOR OCCLUSIVE LESIONS
|
|
x | |
7:46 AM - 7:51 AM | Optimal Treatment For Crural Artery Lesions In 2018 In The US And Elsewhere: Value Of Coronary Drug Eluting Stents (DESs): When And How To Use Them |
Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
7:52 AM - 7:57 AM | Endovascular Stent Treatment Of Common Femoral Artery (CFA) Is Best For All Lesions: Based On The TECCO RCT (Stent vs. Open Endarterectomy): Classification Of Lesions And Subsequent Access Through Stents Is OK |
Presenter(s):Yann Gouëffic, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
7:58 AM - 8:03 AM | Value Of Multiple Short Stents For Treating Fempop Long Lesions: Better Than A Full Metal Jacket: The LOCOMOTIVE Trial Of Vascuflex System (From B. Braun) |
Presenter(s):Thomas Zeller, MD / Peter C.J. Goverde, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
8:04 AM - 8:09 AM | New Findings From The Zilver PTX DES 5-Year RCT And Other Studies Show The Advantages Of This Stent For Fempop Lesions |
Presenter(s):Michael D. Dake, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
8:10 AM - 8:15 AM | Value And Limitations Of Zilver PTX DESs: How Do They Change The Pattern And Volume Of In-Stent Restenosis (ISR) Compared To Other Stents |
Presenter(s):Gary M. Ansel, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
8:16 AM - 8:21 AM | ZILVER PASS RCT Comparing ZILVER PTX DES To PTFE Fempop Bypasses: For TASC C And D Lesions: Zilver PTX Is As Good Or Better At 2 Years |
Presenter(s):Marc Bosiers, MD / Koen R. Deloose, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
8:22 AM - 8:27 AM | 2-Year Results Of The RAPID RCT Comparing Supera Stent Treatment For SFA Lesions With And Without A DCB |
Presenter(s):Jean-Paul de Vries, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
8:28 AM - 8:33 AM | MAJESTIC DES Trial: 3-Year Results For Treatment In Superficial Femoral And Proximal Popliteal Lesions: How Does Eluvia Differ From Other DES |
Presenter(s):Stefan Mueller-Huelsbeck, MD / Thomas Zeller, MD / Dierk Scheinert, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
8:33 AM - 8:38 AM | IMPERIAL Head To Head RCT: 1 Year Results Of The Eluvia DES vs. ZilverPTX For Fempop Lesions |
Presenter(s):William A. Gray, MD / Andrew Holden, MBChB Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
8:39 AM - 8:44 AM | Status Of Bioresorbable DESs For Treating BTK Arteries: Though They Failed In The Coronary Arteries They Show Promise In The Leg: The ABSORB BTK Trial 4-Year Results Show Why |
Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
8:45 AM - 8:58 AM | Panel Discussion |
END OF SESSION 24 | |
SESSION 25 SCHEDULE | |
Wednesday
SESSION 25:
MORE TOPICS RELATED TO COMPLEX LOWER EXTREMITY DISEASE AND ITS TREATMENT: ATHERECTOMY, LITHOPLASTY, OVERCOMING CALCIFICATION BELOW THE KNEE (BTK), TIBIAL ARTERY TREATMENTS, AND COMBINATIONS OF TREATMENTS
|
|
x | |
8:58 AM - 9:03 AM | Atherectomy 2018: When Indicated; Which Device(s) Are Best; Downsides; Precautions; Are Complementary DCBs Necessary |
Presenter(s):Lawrence A. Garcia, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
9:04 AM - 9:09 AM | Histological Evaluation Of Adventitial Injury From Directional Atherectomy: Value Of OCT Guidance |
Presenter(s):Theodosios Bisdas, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
9:10 AM - 9:15 AM | Debulking Atherectomy: Is There Proof It Has Value: In What Circumstances: Which Device Is Best And Why |
Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
9:16 AM - 9:21 AM | Importance Of Debulking And Other Lesion Preparation Strategies With All Drug Eluting Treatments: Why It Is Critical |
Presenter(s):Erwin Blessing, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
9:22 AM - 9:27 AM | Value Of Intravascular Lithotripsy (Shockwave Medical) With And Without DCBs For Treatment Of Calcified Lesions: Single Center Studies And The DISRUPT I, II And III Trial Results |
Presenter(s):Gunnar Tepe, MD / Andrew Holden, MBChB / Thomas Zeller, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
BTK TREATMENTS | |
9:28 AM - 9:33 AM | Present And Future Status Of DCBs: Successes, Failures, Adjuncts Needed, Problems And Solutions: They Will Have A Role In All Vascular Beds Including BTK Arteries |
Presenter(s):Brian G. DeRubertis, MD / Krishna J. Rocha-Singh, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
9:34 AM - 9:39 AM | Shockwave Intravascular Lithotripsy In Calcified Tibial Artery Lesions: How Well Does It Work |
Presenter(s):Andrew Holden, MBChB / Thomas Zeller, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
9:40 AM - 9:45 AM | DCBs vs. DESs For SFA/Pop Lesions: Which Is Best And When With Midterm Follow-Up: From The DRASTICO Trial |
Presenter(s):Francesco Liistro, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
9:46 AM - 9:51 AM | Combination Lesion Treatment With Passeo-18 Lux DCB And Pulsar-18 Uncoated Stent: Advantages And Good Results |
Presenter(s):Koen R. Deloose, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
9:52 AM - 9:58 AM | When Is Distal Embolic Protection Needed During Lower Extremity Interventions: How Should It Be Performed |
Presenter(s):Peter A. Schneider, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
9:58 AM - 10:04 AM | Panel Discussion |
10:04 AM - 10:16 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 25 | |
SESSION 26 SCHEDULE | |
Wednesday
SESSION 26:
NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBs), OTHER DEVICES FOR TREATMENT OF LOWER EXTREMITY OCCLUSIVE LESIONS, RANDOMIZED TRIALS (RCTs) AND BTK TREATMENTS
|
|
x | |
10:16 AM - 10:21 AM | Impact And Significance Of Downstream Embolization And Restenosis With Different DCBs |
Presenter(s):Aloke Finn, MD / Renu Virmani, MD |
|
View Slides in PDF | |
10:22 AM - 10:27 AM | DCBs Are Changing The Landscape And Algorithm For Treating Long Complex SFA/Pop Lesions And Minimizing The Need For Stents: Advantages Of Sirolimus vs. Paclitaxel Coatings |
Presenter(s):Thomas Zeller, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
10:28 AM - 10:33 AM | Update On In.Pact SFA I And II RCTs Show Benefit Of In.Pact (Medtronic) DCBs Persisting And Increasing Over POBA At 4 years With Fem/Pop Lesions |
Presenter(s):John R. Laird, MD / Peter A. Schneider, MD / Gunnar Tepe, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
10:34 AM - 10:39 AM | Update On Persistent Benefit Of Lutonix DCB (Bard/BD) For Fempop Lesions As Shown By A RCT vs. Plain Balloon Angioplasty (POBA): Long Lesions (>14 cm) Were Included |
Presenter(s):Kenneth Rosenfield, MD / Dierk Scheinert, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
10:40 AM - 10:45 AM | COMPARE Pilot RCT: 1 Year Results Of A Randomized Comparison Of RANGER DCB vs. IN.PACT DCB In Complex SFA Lesions |
Presenter(s):Dierk Scheinert, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
10:46 AM - 10:51 AM | Update On ILLUMINATE RCTs With Stellarex DCBs (Spectranetics/Philips): 2- And 3-Year Results For SFA/Pop Lesions And ISR Are Equal To Other DCBs: Advantages Over Other DCBs |
Presenter(s):Sean P. Lyden, MD / Timothy M. Sullivan, MD / Thomas Zeller, MD / Stefan Mueller-Huelsbeck, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
10:52 AM - 10:57 AM | Lessons Learned From The In.Pact DCB GLOBAL Registry - Chronic Total Occlusion (CTO) Cohort: How To Make DCBs Work Best With CTOs |
Presenter(s):Marianne Brodmann, MD / Gunnar Tepe, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
10:58 AM - 11:03 AM | In.Pact DCBs Have Equal Benefits When Treating Long SFA/Pop Lesions As When Treating Shorter Lesions |
Presenter(s):Antonio Micari, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
11:04 AM - 11:11 AM | Panel Discussion |
Moderator(s): Sean P. Lyden, MD / Giancarlo Biamino, MD, PhD | |
11:11 AM - 11:16 AM | What Is The Long-Term Durability Of The Benefits Of The Different DCBs: What Is The Value Of Spot Stenting Of Residual Stenoses With DCBs |
Presenter(s):Gunnar Tepe, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
11:17 AM - 11:22 AM | Present Role For DCBs And DESs For SFA Lesions: Updated Treatment Algorithm And How To Deal With Severe Calcification |
Presenter(s):Fabrizio Fanelli, MD, EBIR Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
11:23 AM - 11:28 AM | Update On Evaluation Of DCBs: When Are They Worthwhile And Advantages Of Different DCBs |
Presenter(s):Gary M. Ansel, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
DCBS FOR BTK LESIONS | |
11:29 AM - 11:34 AM | Value Of DCBs In BTK And Crural Arteries: Reasons For Past Failures: New Technology, New Results And Promising Future Prospects |
Presenter(s):Francesco Liistro, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
11:35 AM - 11:40 AM | Value Of Stellarex DCBs (Spectranetics/Philips) In BTK And Infrapopliteal Artery Lesions |
Presenter(s):Gunnar Tepe, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
11:41 AM - 11:46 AM | > 1-Year Safety And Effectiveness Results Of Lutonix DCBs (Bard/BD) For Treating BTK And Crural Artery Lesions: Late Breaking Update And 6-Month Results Of Lutonix Below-The-Knee Global DCB IDE RCT Study |
Presenter(s):Patrick J. Geraghty, MD / Michael K.W. Lichtenberg, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
11:47 AM - 11:52 AM | Update On Value Of The Chocolate Touch (Restrained) DCB (QT Vascular And TriReme Medical): What Makes It Different And 2-Year Results From The ENDURE Trial |
Presenter(s):Gunnar Tepe, MD / D. Christopher Metzger, MD / Andrew Holden, MBChB / Wei Guo, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
11:53 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break - 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 26 | |
SESSION 27 SCHEDULE | |
Wednesday
SESSION 27:
EXOTIC AND EXTREME NEW TREATMENTS AND TECHNIQUES FOR SEVERE LOWER EXTREMITY OCCLUSIVE DISEASE AND CHRONIC LIMB THREATENING ISCHEMIA (CLTI): DEALING WITH THE “NO OPTION” FOR TREATMENT OR “UNSALVAGEABLE” LIMB AND THE “DESERT FOOT”
Location: Grand Ballroom East, 3rd Floor
Moderators:Daniel G. Clair, MD / Giancarlo Biamino, MD, PhD |
|
x | |
1:00 PM - 1:05 PM | Is No Option CLTI Ever Real: Yes, But Rarely: How To Decrease The Major Amputation Rate: Open Bypasses Have A Role |
Presenter(s):Hisham Rashid, FRCS, FRCS(Gen) Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
1:06 PM - 1:11 PM | Primary Open Bypass Is Better Than Endo-First Approach For CLTI Patients With Extensive Gangrene And Advanced WIfI Lesions |
Presenter(s):Francesco Spinelli, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
1:12 PM - 1:17 PM | Latest Techniques And New Developments In Treating Leg And Foot Artery Lesions Causing CLTI With Extensive Ischemic Gangrene And Ulceration |
Presenter(s):Marco G. Manzi, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
1:18 PM - 1:23 PM | Interventional Strategies For Treating So-Called No Option CLTI Patients: Such Patients Are Becoming Very Rare |
Presenter(s):Erwin Blessing, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
1:24 PM - 1:29 PM | PQ (Percutaneous) Transvenous Arterial Fempop Bypass Procedure: Concept And Technique For Performing (Video) |
Presenter(s):Andrej Schmidt, MD / Dierk Scheinert, MD / James D. Joye, DO Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
1:30 PM - 1:35 PM | Percutaneous (PQ) Transvenous Fempop Arterial Bypass For Long (> 15 cm) SFA Occlusions: The DETOUR I And II Trial 2-Year Results: When Can It Work And When Can It Not |
Presenter(s):Sean P. Lyden, MD / Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
ARTERIALIZATION OF FOOT VEINS | |
1:36 PM - 1:41 PM | Open Surgical Arterial Bypasses To Deep Ankle Veins With Distal Vein Valve Disruption For CLTI With No Distal Target Arteries: Technique And Long-Term Results: It Works |
Presenter(s):Pramook Mutirangura, FRCS (Edinburgh) Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
1:42 PM - 1:47 PM | Percutaneous Deep Vein Arterialization (pDVA) With The LimFlow Device For The No Option Patient With A “Desert” Foot: Technique, Results And Limitations |
Presenter(s):Steven Kum, MD / Daniel G. Clair, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
1:48 PM - 1:53 PM | Pros And Cons Of Hybrid Deep Vein Arterialization Of Foot Veins For No Option CLTI Patients: It Can Work But . . . |
Presenter(s):Roberto Ferraresi, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
1:54 PM - 1:59 PM | Hybrid Venous Arterialization: What Is It: How To Do It And When To Use It For No Option CLTI Patients |
Presenter(s):Miguel F. Montero-Baker, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
2:00 PM - 2:06 PM | Panel Discussion |
END OF SESSION 27 | |
SESSION 28 SCHEDULE | |
Wednesday
SESSION 28:
NEW DEVELOPMENTS IN LOWER EXTREMITY TREATMENTS WITH STENT-GRAFTS AND PROSTHETIC BYPASS GRAFTS; PROGRESS IN TREATING IN STENT RESTENOSIS (ISR)
Location: Grand Ballroom East, 3rd Floor
Moderators:Richard F. Neville, MD / Kenneth Ouriel, MD, MBA |
|
x | |
2:06 PM - 2:11 PM | 8-Year Results Of Heparin Bonded PTFE Viabahn Stent Grafts For The Treatment Of Long TASC C And D Fempop Lesions: Advantages And Limitations |
Presenter(s):Maria Antonella Ruffino, MD, EBIR Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
2:12 PM - 2:17 PM | DEBATE: PTFE Grafts With Bonded Heparin (Propaten) Have Patencies Approaching Those Of Saphenous Vein Grafts For Lower Extremity Bypasses: The Bonded Heparin Makes A Difference |
Presenter(s):Russell H. Samson, MD, RVT, FACS Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
2:18 PM - 2:23 PM | DEBATE: Not So: The Heparin Bonding Is Not The Reason For The Good Results: Other Factors Are More Important |
Presenter(s):Jonathan D. Beard, ChM, MEd, FRCS Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
2:24 PM - 2:29 PM | The SUPER B RCT Shows Viabahn Endografts Perform As Well As Open Surgical Fempop Bypass Grafts For 2 Years: Will DCBs To Prevent Edge Stenosis Improve The Viabahn Results |
Presenter(s):Michel M.P. Reijnen, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
2:30 PM - 2:35 PM | What Is The Best Current Treatment For ISR: DCBs Delay Re-Restenosis But There Is Catch-Up (From The COPA CABANA Trial): So What Is The Solution |
Presenter(s):Gunnar Tepe, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
2:36 PM - 2:41 PM | Value Of Gore Viabahn Endografts To Treat ISR: Tips And Tricks For Successful Durable Use In This Setting |
Presenter(s):Marc Bosiers, MD / Koen R. Deloose, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
2:42 PM - 2:47 PM | New Covered Balloon Expandable Stents: Which Ones Are Available (VBX-Gore; Lifestream-Bard/BD; BeGraft – Bentley): Advantages And Limitations Of Each: Tips For Use |
Presenter(s):Claudio J. Schonholz, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
2:48 PM - 2:53 PM | Comparison Of 4 Balloon Expandable Covered Stents For Treatment Of Aorto- Iliac Occlusive Lesions: iCAST Or Advanta V12 Atrium (Maquet/Getinge); VBX (Gore); Lifestream (Bard/BD); BeGraft (Bentley); Which, Where And When |
Presenter(s):Andrew Holden, MBChB Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
2:54 PM - 3:00 PM | Panel Discussion |
3:00 PM - 3:10 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 28 | |
SESSION 29 SCHEDULE | |
Wednesday
SESSION 29:
LOWER EXTREMITY CLTI AND ITS TREATMENT: WHAT IS ITS BEST TREATMENT; RCTs; METHODS TO ASSESS FOOT PERFUSION AND TREATMENT SUCCESS; VALUE OF ANGIOSOME CONCEPT
|
|
x | |
RCTS AND REGISTRIES OF CLTI TREATMENT | |
3:10 PM - 3:15 PM | Update On The BEST-CLI RCT Comparing Open And Endo Treatments Of CLTI: Recruitment To Date: Successes And Problems To Date: What Will It Tell Us And When |
Presenter(s):Matthew T. Menard, MD / Alik Farber, MD / Kenneth Rosenfield, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
3:16 PM - 3:21 PM | Status Of The BASIL 2 And 3 RCTs: 2 Compares Crural Vein Bypasses With Endo Treatments; 3 Compares DCBs/DESs With PTA And Uncoated Stents: What Will They Tell Us And When |
Presenter(s):Robert J. Hinchliffe, MD / Andrew W. Bradbury, MD, FRCSEd Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
3:22 PM - 3:27 PM | These Trials Will Have Big Problems And May Tell Us Little About Their Primary End Points, But Will Provide Other Valuable Information |
Presenter(s):Mehdi H. Shishehbor, DO, MPH, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
3:28 PM - 3:33 PM | New Findings From The SPINACH Study Of CLTI Treatments Show Bypass First Is Better With Extensive Gangrene And Infection: Otherwise Endo First Is Justified |
Presenter(s):Nobuyoshi Azuma, MD / Osamu Iida, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
3:34 PM - 3:39 PM | Open Bypass Improves Perfusion More Than Endovascular Treatments: The Angiosome Concept Usually Does Not Matter: When Does It |
Presenter(s):Maarit Venermo, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
3:40 PM - 3:45 PM | Duplex Ultrasound Is The Best Technique For Following BTK Interventions: Why It Improves Outcomes Big Time |
Presenter(s):Francesco Liistro, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
3:46 PM - 3:52 PM | Panel Discussion |
ASSESSING FOOT PERFUSION | |
3:52 PM - 3:57 PM | Value Of Lumee Implantable Micro Oxygen Sensors In The Treatment Of CLTI Patients |
Presenter(s):Miguel F. Montero-Baker, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
3:58 PM - 4:03 PM | Can Perfusion Angiography Judge Foot Perfusion And Predict Wound Healing In Patients With CLTI: From The REPEAT Trial |
Presenter(s):Jean-Paul de Vries, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
4:04 PM - 4:09 PM | Perfusion Angiography (From Philips Health Care) To Assess The Functionality Of Sympathetic Activity And Foot Perfusion: It Is A Strong Predictor For Early Amputation In Ischemic Diabetic Foot Disease And A Way To Assess The Effects Of Revascularization Treatments |
Presenter(s):Jim Reekers, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
4:10 PM - 4:15 PM | How To Measure Foot Perfusion After Tibial Interventions: These Measurements Are More Important Than Angiosomes |
Presenter(s):Werner Lang, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
4:16 PM - 4:21 PM | Near Infrared Spectroscopy (NIRS) Is A Novel Non-Invasive Way To Measure Foot Perfusion When Other Methods Fail: How Does It Work And How Does It Help |
Presenter(s):Paolo Zamboni, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
4:22 PM - 4:27 PM | DEBATE: Angiosome Directed Revascularization Improves Wound Healing With CLTI: When Does It Matter |
Presenter(s):Richard F. Neville, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
4:28 PM - 4:33 PM | DEBATE: Why The Angiosome Concept Is Irrelevant In Most CLTI Patients With Tissue Necrosis |
Presenter(s):Jean-Baptiste Ricco, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
4:34 PM - 4:39 PM | Pros And Cons About The Angiosome Concept: What Is Its Real Value And How Can It Improve Limb Salvage |
Presenter(s):Kenneth R. Ziegler, MD / Fred A. Weaver, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
4:40 PM - 4:45 PM | Angiosomes Have Little Value In Diabetic Limb Salvage: WIfI Staging Is A Better Predictor Of Wound Healing Than “Direct” Revascularization |
Presenter(s):Christopher J. Abularrage, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
4:46 PM - 4:52 PM | Panel Discussion |
END OF SESSION 29 | |
SESSION 30 SCHEDULE | |
Wednesday
SESSION 30:
NEW DEVELOPMENTS IN THE TREATMENT OF LOWER EXTREMITY INTERMITTENT CLAUDICATION (IC) AND ACUTE LIMB ISCHEMIA (ALI)
|
|
x | |
4:52 PM - 4:57 PM | How To Get Patients To Recognize That Exercise And Neuromuscular Stimulation (NMES) Are Good Treatments For IC And To Comply With Them |
Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
INTERMITTENT CLAUDICATION | |
4:58 PM - 5:03 PM | Update On Value And Logistics Of Exercise Treatment For Intermittent Claudication (IC): Things Are Getting Better And Why |
Presenter(s):Jonathan D. Beard, ChM, MEd, FRCS Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
5:04 PM - 5:09 PM | A Recently Completed RCT Of Endovascular Revascularization vs. Supervised Exercise For IC: The SUPER Trial Results: Outcomes, QOL And Cost Effectiveness; How Does It Compare With The Other IC RCTs |
Presenter(s):Mark J.W. Koelemay, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
5:10 PM - 5:15 PM | Exercise TcPO2 Can Distinguish Buttock IC From The Symptoms Of Spinal Stenosis: How Should Buttock IC Be Treated |
Presenter(s):Manju Kalra, MBBS Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
5:16 PM - 5:21 PM | New And Current Data On All Cause And Cardiovascular Mortality In Patients With IC And CLTI: Have Recent Improvement In Medical Treatment And Statins Made A Difference |
Presenter(s):Gert J. de Borst, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
5:22 PM - 5:27 PM | Differences In Decision Making For The Treatment Of IC In Europe And The US: Based On Data From The PORTRAIT Registry |
Presenter(s):Jan M.M. Heyligers, MD, PhD, FEBVS Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
5:28 PM - 5:33 PM | Panel Discussion |
ACUTE LIMB ISCHEMIA (ALI) | |
5:33 PM - 5:38 PM | DEBATE: All ALI Patients Should Be Treated With An Endo First Policy And Over 90% Can Be Treated Entirely Endovascularly |
Presenter(s):Ali Amin, MD, RVT, FACS, FACC Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
5:39 PM - 5:44 PM | DEBATE: Not So: Some Patients With ALI Should Have An Open Procedure First And Over 10% Will Require Some Open Component: Which Ones |
Presenter(s):Joseph L. Mills, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
5:45 PM - 5:50 PM | More Effective Treatment Of ALI By Thrombolysis With Microbubbles And Ultrasound |
Presenter(s):Kak Khee Yeung, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
5:51 PM - 5:56 PM | Current And New Data On Morbidity And Mortality Risks After Lower Extremity Embolectomy/Thrombectomy For ALI Open And Endo: Is It Less Than In The Past And Why |
Presenter(s):Alik Farber, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
5:57 PM - 6:02 PM | Advances In The Endovascular Treatment Of ALI: Equipment, Techniques And Results |
Presenter(s):Athanasios Katsargyris, MD / Eric L.G. Verhoeven, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
6:03 PM - 6:09 PM | Panel Discussion End of Program E |
END OF SESSION 30 | |
SESSION 31 SCHEDULE | |
Wednesday
SESSION 31:
NEW DEVELOPMENTS AND ADVANCES IN MEDICAL AND ANTI-ATHEROGENIC TREATMENTS FOR PATIENTS WITH ARTERIAL DISEASE
Location: Grand Ballroom West, 3rd Floor
Moderators:Mehdi H. Shishehbor, DO, MPH, PhD / Geno J. Merli, MD, MACP, FHM, FSVM |
|
x | |
6:40 AM - 6:45 AM | How Long Should Patients With DVT Be Kept On Anticoagulants: A Review Of The Data |
Presenter(s):Geoffrey Barnes, MD, MSc Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
6:46 AM - 6:51 AM | What Are The New AHA Hypertension Guidelines And Why All PAD Patients Should Be Treated According To These Guidelines |
Presenter(s):Jeffrey W. Olin, DO Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
6:52 AM - 6:57 AM | Benefits Of Cilostazol Before And After Peripheral Endovascular Procedures: What Regimen And Dosage Should Be Given Routinely |
Presenter(s):Gary M. Ansel, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
6:58 AM - 7:03 AM | What Is Anacetrapib: Do CETP Inhibitors To Reduce LDL Cholesterol (LDL-C) More Than Statins Have A Role In PAD Patients: What About Ezetemibe (Zetia): How Low An LDL-C Should We Try To Get |
Presenter(s):Kavita Sharma, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
7:04 AM - 7:09 AM | PCSK-9 Inhibitors: Highlights For The Vascular Specialist In 2018 |
Presenter(s):Pradeep Natarajan, MD, MMSc Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
7:10 AM - 7:15 AM | DEBATE: Statins Are Dangerous Drugs: Lowering LDL-C Does No Good And Is Harmful In Most Patients |
Presenter(s):Sherif A.H. Sultan, MD, FRCS, EBQS-VASC Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
7:16 AM - 7:21 AM | DEBATE: Not So: Lowering LDL-C Levels With Statins And PCSK-9 Inhibitors In At Risk Patients With PAD Prevents Cardiovascular Events And Deaths; It Is Safe And Prolongs Life |
Presenter(s):Ron Waksman, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
7:22 AM - 7:27 AM | How Important Is It To Give High Intensity Statins To PAD Patients: How Low Should We Push Their LDL-C, To <50 mg/dL; What About Adding Other Drugs: What About Statins In Older (>80) PAD Patients |
Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC / Caron B. Rockman, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
7:28 AM - 7:33 AM | DEBATE: What Did The COMPASS RCT Show: After This Trial, Rivaroxaban Plus Aspirin Should Be Given To All PAD Patients To Lower Their Risk Of Stroke, MI And Death: What Doses |
Presenter(s):Jay Giri, MD, MPH Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
7:34 AM - 7:39 AM | DEBATE: Not So Fast: We Still Need To Know More Before Adding Rivaroxaban For PAD Patients |
Presenter(s):Brian H. Annex, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
7:40 AM - 7:46 AM | Panel Discussion |
END OF SESSION 31 | |
SESSION 32 SCHEDULE | |
Wednesday
SESSION 32:
MORE ON MEDICAL TREATMENTS AND NEW TECHNIQUES FOR TREATING RESISTANT HYPERTENSION; PREDICTIONS FOR THE FUTURE
Location: Grand Ballroom West, 3rd Floor
Moderators:David H. Deaton, MD, FACS / Ido Weinberg, MD, MSc |
|
x | |
7:46 AM - 7:51 AM | Can Renal Denervation Still Be An Effective Treatment For Resistant Hypertension: Results With The Spyral-HTN Device (Medtronic) In A Sham Controlled RCT Suggest It Can: What About Other Endovascular Treatments |
Presenter(s):Horst Sievert, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
7:52 AM - 7:57 AM | The Mobius HD Intra-Arterial Implant (From Vascular Dynamics) To Stimulate Baroreceptor Activity And Lower BP (The CALM-2 Trial): How Does It Work And Results To Date |
Presenter(s):Kim J. Hodgson, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
7:58 AM - 8:03 AM | The ROX Coupler To Create An Iliac A-V Fistula And Control Resistant Hypertension: Positive Results Of The CONTROL HTN-2 Sham Controlled RCT: Will Blood Pressure Measurement With Light-Sensitive Finger Photoplethysmography Become A Reality |
Presenter(s):David H. Deaton, MD, FACS / Krishna J. Rocha-Singh, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
8:04 AM - 8:09 AM | DEBATE: Beta Blockers Lower The Postoperative Mortality Of Patients Undergoing Open Repair Of AAAs: What Drug Dose And Timing Should Be Used |
Presenter(s):Mahmoud B. Malas, MD, MHS Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
8:10 AM - 8:15 AM | DEBATE: The Evidence Supporting The Value Of Peri-Operative Beta Blockers In Lowering Morbidity Of Vascular Procedures Is Weak And They May Be Harmful: What Should We Do: Is It Just A Dosage Problem |
Presenter(s):Peter Henke, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
8:16 AM - 8:21 AM | What Is The Optimal Medical Treatment For Patients With CLTI; With PAD: How Much Will Medical Treatment Replace Invasive Interventions By 2028 |
Presenter(s):Ido Weinberg, MD, MSc / Michael R. Jaff, DO Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
8:22 AM - 8:28 AM | Panel Discussion |
8:28 AM - 8:33 AM | Adherence To Lipid Guidelines (Which Ones) In CLTI Patients Undergoing Open And Endo Revascularization Leads To A Decrease In Mortality And Major Adverse Limb Events (MALEs): How Low Should The LDL-C Be Pushed |
Presenter(s):Marc L. Schermerhorn, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
8:34 AM - 8:39 AM | Implications Of The CANTOS Trial Showing That An Anti-Inflammatory Drug (Canakinumab From Novartis) Reduces Strokes, MIs And Deaths Without Changing LDL-C Levels |
Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC / Caron B. Rockman, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
8:40 AM - 8:45 AM | PCSK-9 Inhibitor (Evolocumab) Plus Statins Decreases MI, Stroke, MALE And Death More In PAD And Recent MI Patients Than Others: From A FOURIER RCT Trial Subanalysis: What LDL-C Level Should We Aim For |
Presenter(s):Caron B. Rockman, MD / Jeffrey S. Berger, MD, MS, FAHA, FACC Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
8:46 AM - 8:51 AM | The Best Antiplatelet And Anticoagulant Medications For Patients With Aggressive PAD: How Important Are LDL-C Levels: When Should Ezetemibe (Zetia) And PCSK-9 Inhibitors Be Added To Statins |
Presenter(s):Peter Henke, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
8:52 AM - 8:57 AM | Is There A Future For Bioresorbable Stents In The Coronary Arteries Or Elsewhere |
Presenter(s):Ron Waksman, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
8:58 AM - 9:04 AM | Panel Discussion |
END OF SESSION 32 | |
SESSION 33 SCHEDULE | |
Wednesday
SESSION 33:
PROGRESS IN THE MANAGEMENT OF COMPLICATIONS AND ENDOLEAKS
|
|
x | |
9:04 AM - 9:09 AM | Retroperitoneal Hemorrhage Is Life-Threatening: Vascular Specialists Should Never Cause It: How To Prevent It: How To Diagnose And Treat It |
Presenter(s):Russell H. Samson, MD, RVT, FACS Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
9:10 AM - 9:15 AM | Lower Extremity Ischemic Complications With EVAR And F/EVAR: Causes And Treatment |
Presenter(s):Thomas S. Maldonado, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
ENDOLEAKS AFTER EVAR | |
9:16 AM - 9:21 AM | Management Strategies For Type 1a Endoleaks After EVAR: When Can They Be Ignored And When Must They Be Treated: What Treatment Is Best And When |
Presenter(s):Murray L. Shames, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
9:22 AM - 9:27 AM | When Can Embolization Techniques Fix Type 1 Endoleaks After EVAR: Which Agents Are Best And Technical Tips |
Presenter(s):Robert A. Morgan, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
9:28 AM - 9:33 AM | DEBATE: Type 2 Endoleaks With Increasing AAA Sac Size Are Dangerous And Usually Must Be Treated: Here Is The Evidence |
Presenter(s):Jean-Pierre Becquemin, MD, FRCS Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
9:34 AM - 9:39 AM | DEBATE: There Is No Evidence That Treating Type 2 Endoleaks Is Beneficial And Such Treatment May Be Harmful |
Presenter(s):Hence J.M. Verhagen, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
9:40 AM - 9:45 AM | Transcaval Embolization Of Type 2 Endoleaks After EVAR: Indications, Technique, Precautions And Results |
Presenter(s):Clifford M. Sales, MD, MBA, FACS Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
9:46 AM - 9:51 AM | Contrast Enhanced Ultrasound (CEUS) To Facilitate Effective Treatment Of Type 2 Endoleaks |
Presenter(s):Thanila A. Macedo, MD / Gustavo S. Oderich, MD, FACS Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
9:52 AM - 9:57 AM | When And How To Treat Type 2 Endoleaks: How Often Is Treatment Effective; How Often Is It Not |
Presenter(s):Marc L. Schermerhorn, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
9:58 AM - 10:03 AM | Onyx To Treat Type 2 Endoleaks: Technique And Precautions To Do It Safely And Effectively And Be Sure It Gets Into The Nidus |
Presenter(s):Mark W. Mewissen, MD, RVT Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
10:04 AM - 10:12 AM | Panel Discussion |
10:12 AM - 10:28 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 33 | |
SESSION 34 SCHEDULE | |
Wednesday
SESSION 34:
TRIBUTES TO VASCULAR GREATS; ISSUES RELATED TO A VASCULAR PRACTICE – PROBLEMS TO BE FACED AND HOW TO DEAL WITH THEM AND SUCCEED: ARTIFICIAL INTELLIGENCE AND HISTORY
|
|
x | |
A BIT OF HISTORY | |
10:28 AM - 10:33 AM | My Diversion To Gander, Newfoundland On 9/11/2001 And What It Taught Me: The Play “Come From Away” Brought Back Memories |
Presenter(s):Klaus D. Mathias, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
TRIBUTES TO GIANTS | |
10:34 AM - 10:39 AM | A Tribute To Frank A. Lederle, MD (1952-2018) |
Presenter(s):Jerry Goldstone, MD, FACS, FRCSEd Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
10:40 AM - 10:45 AM | A Tribute To Anthony (Tony) M. Imparato (1922-2018) |
Presenter(s):Mark A. Adelman, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
ISSUES FOR VASCULAR SURGEONS | |
10:46 AM - 10:51 AM | Is The Double Booked Vascular Surgeon A Thing Of The Past: Not Totally: What Are The Limitations |
Presenter(s):Vincent J. Santo III, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
10:52 AM - 10:57 AM | White Coat Crime In Vascular Surgery: What Is It And How Can It Be Stopped |
Presenter(s):Russell H. Samson, MD, RVT, FACS Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
10:58 AM - 11:03 AM | Physical Ailments That Accrue To Vascular Surgeons From Their Work: What Are The Causes: How To Measure And Prevent Them |
Presenter(s):Samuel R. Money, MD, MBA Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
11:04 AM - 11:11 AM | Panel Discussion |
11:11 AM - 11:16 AM | Life After Being A Busy Successful Surgeon: When And How To Stop Operating And Still Have A Useful Enjoyable Life |
Presenter(s):Simran B. Singh, MD, MBA Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
11:17 AM - 11:22 AM | How Can Vascular Surgeon-Scientists Survive In Today’s Unfriendly DRG/RVU Climate |
Presenter(s):Peter Henke, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
11:23 AM - 11:28 AM | Key Personal Qualities That Help One To Achieve Success In Vascular Surgery And Other Vascular Specialties |
Presenter(s):Tej M. Singh, MD, MBA Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
11:29 AM - 11:34 AM | Challenges And Keys To Success For Women In Vascular Surgery |
Presenter(s):Rebeca Reachi Lugo, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
11:35 AM - 11:40 AM | What Measures Need To Be Taken To Promote The Well-Being Of Vascular Surgeons In Today’s Medical Climate |
Presenter(s):Cynthia K. Shortell, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
ARTIFICIAL INTELLIGENCE IN MEDICINE | |
11:41 AM - 11:46 AM | Role Of Artificial Intelligence And Big Data In Health Care: Are Doctors’ Jobs In Danger |
Presenter(s):Ido Weinberg, MD, MSc Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
11:47 AM - 11:52 AM | How Innovation Is Changing Health Care: Artificial Intelligence, Amazon, Google, Etc. Will Revolutionize Things In the Future |
Presenter(s):Eugene M. Langan III, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
11:53 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break - 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 34 | |
SESSION 35 SCHEDULE | |
Wednesday
SESSION 35:
ISSUES RELATED TO OUTPATIENT CENTERS, PODIATRY, REIMBURSEMENTS, PERFORMANCE AND COST CONTROL
|
|
x | |
1:00 PM - 1:05 PM | Office Or Outpatient Centers Are The Best Place To Perform Most Arterial And Venous Interventional Treatments: Precautions And Current Status Of Their Accreditation And Reimbursement |
Presenter(s):Krishna Jain, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
1:06 PM - 1:11 PM | What Is The OEIS (Outpatient Endovascular And Interventional Society); How Can It Help Vascular Surgeons And Specialists And Their Patients |
Presenter(s):Jeff G. Carr, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
1:12 PM - 1:17 PM | DEBATE: Outpatient Atherectomy For IC (Claudication) Leads To Worse Outcomes And More Amputations Than The Natural History Of The Disease: From Medicare Billing Data |
Presenter(s):Dipankar Mukherjee, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
1:18 PM - 1:23 PM | DEBATE: Not So: Why Outpatient Atherectomy Should Not Increase Amputation Rates But Should Decrease Them: Why The Medicare Data Is Misleading |
Presenter(s):Lawrence A. Garcia, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
1:24 PM - 1:29 PM | New Concepts In Podiatry Important To Vascular Surgeons/Specialists: Game Changing Single Dose Antibiotic (Dalbavancin) For Foot Infections And How To Avoid Opiods For Pain |
Presenter(s):Wayne J. Caputo, DPM Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
1:30 PM - 1:35 PM | Panel Discussion |
REIMBURSEMENT AND COST ISSUES | |
1:35 PM - 1:40 PM | What Is Happening With MACRA And The Other Alphabet Soup Entities Impacting On Reimbursement |
Presenter(s):Timothy F. Kresowik, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
1:41 PM - 1:46 PM | Why Endovascular Treatments For CLTI Are More Cost Effective Than Open Surgery Or Amputation In The Drug Eluting Era |
Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
1:47 PM - 1:52 PM | Strategies For Decreasing Costs Without Decreasing Success In A PVD Practice |
Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
1:53 PM - 1:58 PM | What Are The Latest Objective SFA-Pop Performance Goals: How Do They Influence Patient Care And Costs |
Presenter(s):Jack L. Cronenwett, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
1:59 PM - 2:04 PM | V-HEALTHY: A Program To Increase Vascular Disease Awareness And The Role And Importance Of Vascular Surgeons: How Does It Work |
Presenter(s):Manish Mehta, MD, MPH Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
2:05 PM - 2:11 PM | Innovation In Vascular Surgery: What Does It Take To Develop A New Treatment And Change The Standard Of Care |
Presenter(s):Frank J. Criado, MD, FACS, FSVM Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
2:11 PM - 2:16 PM | Panel Discussion |
END OF SESSION 35 | |
SESSION 36 SCHEDULE | |
Wednesday
SESSION 36:
MORE ISSUES RELATED TO QUALIFICATIONS, GOVERNMENT, COMPENSATION OR INCOMES, INCENTIVES, PUBLIC REPORTING OF OUTCOMES, PROCEDURAL USAGE AND VALUE OF VASCULAR SURGEONS
Location: Grand Ballroom West, 3rd Floor
Moderators:Keith D. Calligaro, MD / Bruce A. Perler, MD, MBA |
|
x | |
2:16 PM - 2:21 PM | Why European Qualifications In Vascular Surgery Will Have Increasing Importance: How Will It Help Vascular Surgeons And Patients |
Presenter(s):Armando Mansilha, MD, PhD, FEBVS Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
2:22 PM - 2:27 PM | What Is Happening With Vascular Device Evaluation And Approval At The FDA: How Is It Helping Vascular Surgeons Develop And Get To Use New Devices |
Presenter(s):Dorothy B. Abel, BSBME Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
2:28 PM - 2:33 PM | How Is The SVS Coding And Government Relations Committees And The SVS PAC Helping Vascular Surgeons’ Incomes |
Presenter(s):Sean P. Roddy, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
2:34 PM - 2:39 PM | How To Design A Fair Compensation Package For Academic Vascular Surgeons: It Should Not Just Be About RVUs And DRGs |
Presenter(s):Mark G. Davies, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
2:40 PM - 2:45 PM | Pay For Performance (P4P) Incentive Systems Are Flawed: What Frustrations Do They Cause For Vascular Surgeons/Specialists Dealing With High Risk Patients And How Can These Be Overcome |
Presenter(s):James W. Jones, MD, PhD, MHA Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
2:46 PM - 2:52 PM | Panel Discussion |
2:52 PM - 2:57 PM | DEBATE: Public Reporting Of Individual Vascular Surgeons And Other Vascular Specialists Is A Good Thing For Patients |
Presenter(s):Bruce A. Perler, MD, MBA Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
2:58 PM - 3:03 PM | DEBATE: No: Such Reporting Is Bad For Patients, Society And Specialists: Here Is Why |
Presenter(s):Ian Loftus, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
3:04 PM - 3:09 PM | Factors Influencing Usage Of Procedures (Like Carotid Revascularizations) By Doctors: Maintenance Of Incomes Is A Major Factor And Could Be Detrimental To Patients |
Presenter(s):Philip P. Goodney, MD, MS Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
3:10 PM - 3:15 PM | Why Do Some Alleged Vascular Surgeons Perform 1 Or 2 AAA Repairs Per Year: What Is The Result And How Can The Problem Be Fixed |
Presenter(s):Jack L. Cronenwett, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
3:16 PM - 3:21 PM | Urgent Operative Consultations Provided By Vascular Surgeons - Usually To Stop Bleeding: Skills We Have That Others Need: Can Our Value Be Compensated And Is It |
Presenter(s):Michael Belkin, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
3:22 PM - 3:27 PM | Panel Discussion |
3:27 PM - 3:36 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 36 | |
SESSION 37 SCHEDULE | |
Wednesday
SESSION 37:
ISSUES RELATED TO MALPRACTICE, VASCULAR CARE AND THE VALUE AND WELL-BEING OF VASCULAR SURGEONS
Location: Grand Ballroom West, 3rd Floor
Moderators:Michel Makaroun, MD / R. Clement Darling III, MD |
|
x | |
3:36 PM - 3:41 PM | How To Neutralize And Unmask Hostile Medical Expert Witnesses And Their Testimony |
Presenter(s):O. William Brown, MD, JD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
3:42 PM - 3:47 PM | Why Is The EPIC EHR System Currently Such A Problem For Vascular Surgeons/Specialists: Can It Be Improved: Are There Better Systems |
Presenter(s):Timothy F. Kresowik, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
3:48 PM - 3:53 PM | How To Decrease The Cost Of Vascular Care Delivery For Lower Extremity And EVAR Procedures Without Impairing Quality |
Presenter(s):Richard J. Powell, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
3:54 PM - 3:59 PM | How To Let Vascular Patients Share More In Their Treatment Decisions: What Tools Are Available: The OVIDIUS Trial |
Presenter(s):Dirk T. Ubbink, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
4:00 PM - 4:05 PM | EVAR And Carotid Interventions Can Have Durable Good Results In Patients Over 80: How Can Results Be Improved In Elderly Patients |
Presenter(s):B. Patrice Mwipatayi, MMed, MClinEd Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
4:06 PM - 4:11 PM | Eliminating Avoidable Disasters In The OR And Managing Them When They Occur |
Presenter(s):Robert B. McLafferty, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
4:12 PM - 4:17 PM | Panel Discussion |
4:17 PM - 4:22 PM | Why We Need To Centralize Vascular Care For AAAs And CLTI: Will It Happen |
Presenter(s):Michael C. Stoner, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
4:23 PM - 4:28 PM | How A Certification Plan For Vascular Centers Will Be Structured: Will It Happen And How Will It Help Vascular Surgery |
Presenter(s):Anton N. Sidawy, MD, MPH Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
4:29 PM - 4:34 PM | Recognition Of Burnout In Vascular Surgeons: Strategies To Prevent And Overcome It |
Presenter(s):John (Jeb) W. Hallett, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
4:35 PM - 4:40 PM | How To Optimize And Reward The Value Of A Vascular Surgeon In A Large Health Care System |
Presenter(s):Ronald M. Fairman, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
4:41 PM - 4:46 PM | Panel Discussion |
END OF SESSION 37 | |
SESSION 38 SCHEDULE | |
Wednesday
SESSION 38:
ISSUES RELATED TO THE SVS, VQIs, GUIDELINES, TRIALS, ETHICS AND THE JVS
Location: Grand Ballroom West, 3rd Floor
Moderators:Kenneth Ouriel, MD, MBA / Anton N. Sidawy, MD, MPH |
|
x | |
4:46 PM - 4:51 PM | Current Status, Advantages And Limitations Of The SVS VQI |
Presenter(s):Larry W. Kraiss, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
4:52 PM - 4:57 PM | How VQIs Can Be Used To Help Set Ethical Standards |
Presenter(s):Thomas W. Wakefield, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
4:58 PM - 5:03 PM | How VQIs Can Help To Develop Good RCTs |
Presenter(s):Mohammad H. Eslami, MD, MPH Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
5:04 PM - 5:09 PM | Highlights And Key Messages From The New SVS Practice Guidelines For Care Of AAA Patients |
Presenter(s):Elliot L. Chaikof, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
5:10 PM - 5:15 PM | Highlights And Key Messages From The UK Guidance Document On AAA Treatment |
Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
5:16 PM - 5:21 PM | SVS Guidelines For Hospital Privileges For Vascular Surgeons In The US |
Presenter(s):Keith D. Calligaro, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
5:22 PM - 5:27 PM | Panel Discussion |
5:27 PM - 5:32 PM | Why Registries Can Be Better Than RCTs For Evaluating Vascular Devices |
Presenter(s):Jean-Baptiste Ricco, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
5:33 PM - 5:38 PM | Traditional Clinical Trials In Vascular Disease Have Problems: How Can We Fix This With Bayesian Trial Designs |
Presenter(s):Charles C. Miller, PhD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
5:39 PM - 5:44 PM | Why Do So Many Trials Of Treatments For CLTI Fail: What Is The Best Design To Prevent Failure In This Setting |
Presenter(s):Mahmood Razavi, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
5:45 PM - 5:50 PM | Update On Status Of And Improvements In The JVS: How To Review A Paper For The JVS |
Presenter(s):Peter F. Lawrence, MD / Peter Gloviczki, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
5:51 PM - 5:56 PM | How To Make A Paper Have The Best Chance Of Getting Published In The JVS Despite A High Rejection Rate |
Presenter(s):Peter Gloviczki, MD / Peter F. Lawrence, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
5:57 PM - 6:03 PM | Panel Discussion End of Program F |
END OF SESSION 38 | |
SESSION 39 SCHEDULE | |
Wednesday
SESSION 39:
MORE TOPICS RELATED TO THE THORACIC AORTA, TEVAR, AORTIC DISSECTIONS AND THEIR TREATMENT
|
|
x | |
6:45 AM - 6:50 AM | Why Left Subclavian Artery (LSA) Revascularization With TEVAR Is Best Accomplished With A Carotid-To-Axillary Bypass Rather Than By A Carotid-To-LSA Bypass Or Transposition: Technical Tips |
Presenter(s):Frank J. Criado, MD, FACS, FSVM Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
6:51 AM - 6:56 AM | System For Preoperative Risk Assessment For TEVAR Outcomes |
Presenter(s):Richard G.J. Gibbs, FRCS Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
6:57 AM - 7:02 AM | How Best To Size (Diameter) Endografts For TEVAR: For Treatment Of Aneurysms, TBADs And Traumatic Aortic Injuries |
Presenter(s):Thomas S. Maldonado, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
7:03 AM - 7:08 AM | At What Size (Diameter) Should Asymptomatic Thoracic Aortic Aneurysms (TAAs) Undergo Treatment By TEVAR |
Presenter(s):Robert J. Hinchliffe, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
7:09 AM - 7:14 AM | Impact Of TEVAR On Pulsatile Aortic Strain In Acute TBAD: What Is Its Clinical Significance |
Presenter(s):Frans L. Moll, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
7:15 AM - 7:20 AM | Panel Discussion |
TBAD RELATED TOPICS | |
7:20 AM - 7:25 AM | 4-Year Outcomes Of TBAD Treatment With The Valiant Device (From Medtronic) For TEVAR |
Presenter(s):Ali Azizzadeh, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
7:26 AM - 7:31 AM | Invasive Treatment In Patients With Genetically Triggered Aortopathy (Like Marfan’s): When Is Endovascular Treatment Acceptable And When Not |
Presenter(s):Cherrie Z. Abraham, MD |
|
View Slides in PDF | |
7:32 AM - 7:37 AM | Risk Factors For New Distal Endovascular Graft Induced Re-Entry Tears After TEVAR For TBADs: How To Avoid Them |
Presenter(s):Ludovic Canaud, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
7:38 AM - 7:43 AM | Importance Of The Primary Tear Distance From The LSA In Predicting Aortic Growth With TBADs |
Presenter(s):William D. Jordan Jr., MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
7:44 AM - 7:49 AM | When And How To Intervene For Endoleaks And False Lumen Perfusion After TEVAR For TBADs |
Presenter(s):Manish Mehta, MD, MPH Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
7:50 AM - 7:55 AM | How Can False Lumen Intentional Placement (FLIP) Of An Endograft Facilitate Repair Of A Chronic TBAD With TAAA Formation: Techniques And Results |
Presenter(s):William J. Quinones-Baldrich, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
7:56 AM - 8:01 AM | Panel Discussion |
END OF SESSION 39 | |
SESSION 40 SCHEDULE | |
Wednesday
SESSION 40:
MORE NEW DEVELOPMENTS IN THE TREATMENT OF LESIONS OF THE ASCENDING AORTA AND THE AORTIC ARCH
|
|
x | |
8:01 AM - 8:06 AM | Risk Factors For Retrograde Type A Dissections After TEVAR Procedures And How To Avoid Them And Treat Them |
Presenter(s):Frank R. Arko, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
8:07 AM - 8:12 AM | Ascending Aortic Aneurysms Are Over-Diagnosed Using Cardiology Guidelines: When Is The Ascending Aorta Really Aneurysmal |
Presenter(s):Jes S. Lindholt, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
8:13 AM - 8:18 AM | Early Multicenter Experience With The Gore Ascending Aortic Off-The-Shelf (OTS) Endograft: Indications, Contraindications, Advantages And Results |
Presenter(s):Jean Bismuth, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
8:19 AM - 8:24 AM | Technical Tips For Open Arch Replacement In Type A Aortic Dissections (TAADs) To Facilitate Subsequent TAAA Repair |
Presenter(s):Christian D. Etz, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
8:25 AM - 8:30 AM | Chimney TEVAR (Ch/TEVAR) To Treat Aortic Arch Lesions: Long-Term Good Outcomes And How To Achieve Them |
Presenter(s):Martin R. Back, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
8:31 AM - 8:36 AM | How To Prevent Gutter Endoleaks With Arch Chimney Grafts (Ch/TEVAR) |
Presenter(s):Jan S. Brunkwall, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
8:37 AM - 8:43 AM | Panel Discussion |
8:43 AM - 8:48 AM | New Concepts For Better Understanding Aortic Arch Pathology, Its Progression And Treatment |
Presenter(s):Santi Trimarchi, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
8:49 AM - 8:54 AM | Retrograde Type A Aortic Dissections After TEVAR: Etiologic Factors Can Be Operator Dependent; Device Dependent And/Or Disease Dependent: How To Prevent And Treat Them |
Presenter(s):Ourania Preventza, MD / Joseph S. Coselli, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
8:55 AM - 9:00 AM | Open vs. Endo Arch Reconstructions In 2018: What Is Evidence-Based And What Is Anecdote-Based |
Presenter(s):Christoph A. Nienaber, MD, PhD / Nicholas J.W. Cheshire, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
9:01 AM - 9:06 AM | Update On The Gore Retrograde Single Branched Endograft Device For Treating Aortic Arch Lesions: Advantages, Precautions And Results |
Presenter(s):Michael D. Dake, MD / Michel Makaroun, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
9:07 AM - 9:12 AM | Percutaneous Transapical Approach For Placing Arch And Other Devices: How Is It Possible |
Presenter(s):Ross Milner, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
9:13 AM - 9:18 AM | How To Manage A Chronically Diseased Aorta Distal To A Previous Surgical Or Endograft Treated TAAD |
Presenter(s):Jean-Marc Alsac, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
9:19 AM - 9:25 AM | Panel Discussion |
9:25 AM - 9:40 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 40 | |
SESSION 41 SCHEDULE | |
Wednesday
SESSION 41:
MORE ABOUT JUXTA- AND PARARENAL AAAs, F/B/EVAR, TAAAs, NEW ENDOGRAFTS, SANDWICH GRAFTS AND HYBRID GRAFTS
|
|
x | |
9:40 AM - 9:45 AM | New Advances In Open TAAA Repair Especially After Endovascular Treatment Failures: Technical Tips And Results |
Presenter(s):Roberto Chiesa, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
9:46 AM - 9:51 AM | DEBATE: Endovascular Repair Is The Best Treatment For Most TAAAs – Especially With The Availability Of Some Newer Endograft Systems |
Presenter(s):Mark A. Farber, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
9:52 AM - 9:57 AM | DEBATE: Not So: Many TAAAs Are Best Treated By Open Surgery: Technical Pearls To Improve Results |
Presenter(s):Virendra I. Patel, MD, MPH Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
9:58 AM - 10:03 AM | Why Open Surgery Is Still The Best Treatment For Juxta- And Pararenal AAAs In Good Risk Patients: Technical Tips |
Presenter(s):Kimihiro Komori, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
10:04 AM - 10:09 AM | Update On The Sandwich Technique For Treating Complex TAAAs: Technical Tips, Precautions And Results |
Presenter(s):Armando C. Lobato, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
10:10 AM - 10:15 AM | Endovascular Options For Treating TAAAs: What Off-Label Options Are Safe And Effective |
Presenter(s):Murray L. Shames, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
10:16 AM - 10:21 AM | Propensity Matched Comparison Of F/B/EVAR And Open Repair For TAAAs Shows That Endovascular Treatment Is Best |
Presenter(s):Piergiorgio Cao, MD, FRCS Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
10:22 AM - 10:27 AM | Tips And Tricks For Performing B/EVAR Without Axillary Access |
Presenter(s):Stephan Haulon, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
10:28 AM - 10:34 AM | Panel Discussion |
Moderator(s): Stephan Haulon, MD / Ali F. AbuRahma, MD | |
10:34 AM - 10:39 AM | Visceral Manifold Endograft System From Medtronic For Treating Complex AAAs And TAAAs: Advantages, Precautions And Midterm Results: When Will It Be Available Commercially |
Presenter(s):Patrick W. Kelly, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
10:40 AM - 10:45 AM | Update On A New Manifold Multibranched Endo Device (Colt Device) For Improving TAAA Treatment: Concept, Advantages And Results |
Presenter(s):Piotr Szopinski, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
10:46 AM - 10:51 AM | Update On The Spider Hybrid Graft For Partially Open TAAA Repair Without A Thoracotomy: How It Works, Clinical Experience, Advantages And Limitations |
Presenter(s):Sebastian E. Debus, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
10:52 AM - 10:57 AM | Open Repair For Visceral Segment TAAAs After TEVAR: The Reverse Cactus Operation: A Good Option When Endo Treatment Is Not Possible: Technique And 1-Year Results |
Presenter(s):Francesco Spinelli, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
10:58 AM - 11:03 AM | Chimney EVAS (Ch/EVAS) With The Nellix Device For Juxta- And Pararenal AAAs: Tips And Tricks For Performing And Results Of The ASCEND Trials 1 And 2 (IDE) |
Presenter(s):Ian Loftus, MD / Pete Holt, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
11:04 AM - 11:09 AM | Branched EVAR (B/EVAR) Through The False Lumen For Chronic TBADs With TAAAs: Why Is It Necessary: How To Do It And Results |
Presenter(s):Piotr M. Kasprzak, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
11:10 AM - 11:15 AM | Adjuncts To Achieve Better Sealing And AAA Exclusion With F/EVAR And Ch/EVAR: Value Of Viabahn BX (Balloon Expandable) Branch Grafts As Shown In An In Vitro Model |
Presenter(s):Jan D. Blankensteijn, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
11:16 AM - 11:22 AM | Panel Discussion |
END OF SESSION 41 | |
SESSION 42 SCHEDULE | |
Wednesday
SESSION 42:
UPDATE ON MULTILAYER FLOW MODULATING BARE STENTS FOR THE TREATMENT OF PERIPHERAL AND VISCERAL ANEURYSMS, COMPLEX AORTIC ANEURYSMS AND DISSECTIONS
|
|
x | |
11:22 AM - 11:27 AM | Why Multilayer Flow Modulating Bare Stents (From Cardiatis) Are The Treatment Of Choice For Peripheral And Visceral Aneurysms: What Is The Evidence: These Are The Results |
Presenter(s):Michel Henry, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
11:28 AM - 11:33 AM | Update On The Value Of Treating Aortic Aneurysms And Dissections With A Combination Of Multilayered Uncovered Stents Together With Covered Stents: Indications, Techniques And Results |
Presenter(s):Qingsheng Lu, MD / Zaiping Jing, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
11:34 AM - 11:39 AM | When Is The Multilayered Flow Modulating Bare Stent A Good Treatment For TBADs And The Treatment Of Choice For Penetrating Aortic Ulcers (PAUs): Indications, Precautions And Results |
Presenter(s):Ralf R. Kolvenbach, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
11:40 AM - 11:45 AM | Multilayer Flow Modulating Bare Stents: Long-Term Results In Aortic Dissections And Complex AAAs And TAAAs: When Do They Work And When Don’t They: From The DRAGON Multicenter Trial |
Presenter(s):Claude D. Vaislic, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
11:46 AM - 11:51 AM | Value Of Multilayer Flow Modulating Stents In Treating Complex Aortic Pathology: They Are Effective In Aortic Dissections: What About With Complex AAAs |
Presenter(s):Ivo Petrov, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
11:52 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 42 | |
SESSION 43 SCHEDULE | |
Wednesday
SESSION 43:
MORE INTERESTING TOPICS RELATED TO INFRARENAL AAAs AND STANDARD EVAR AND TBADs
|
|
x | |
1:00 PM - 1:05 PM | Off-Label Use Of EVAR Devices For Treating AAAs With Challenging Neck Anatomy Is Safe And Effective Under Certain Conditions: What Are They |
Presenter(s):Martin Malina, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
1:06 PM - 1:11 PM | Should Mesh Reinforcement Of Abdominal Incisions Be The Standard Of Care For Open AAA Surgery To Prevent Wound Complications: Based On RCTs |
Presenter(s):Mark J.W. Koelemay, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
1:12 PM - 1:17 PM | Multilayer Flow Modulating (MFM) Stents Are A Safe And Effective Option For Treating Complex Type B Aortic Dissections (TBADs): Based On A 4-Year Experience |
Presenter(s):Victor S. Costache, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
1:18 PM - 1:23 PM | EVAR 2’s Level 1 Evidence No Longer Applies For Many Reasons: Why EVAR Is Currently Indicated In Many Patients Unfit For Open Repair: Which Ones |
Presenter(s):Frank E.G. Vermassen, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
1:24 PM - 1:29 PM | Of Course EVAR Is Indicated In Many Patients Who Could Not Undergo An Open Repair: This Is An Example Of RCT Level 1 Evidence Being Outdated And No Longer Applicable To Current Practice |
Presenter(s):Edward Y. Woo, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
1:30 PM - 1:35 PM | How To Treat Patients With Large AAAs Who Are Unfit For Open Repair In 2018: When Should They Undergo EVAR |
Presenter(s):Katariina M. Noronen, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
1:36 PM - 1:41 PM | Why EVAR 2 Level 1 Evidence May Not Apply In 2018 And Why Patients Unfit For Open Repair May Now Benefit From EVAR |
Presenter(s):Cynthia K. Shortell, MD / Leila Mureebe, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
1:42 PM - 1:47 PM | New Insights Into Long-Term Reintervention And AAA Rupture Rates After EVAR And Open Repair: From The SVS VQI |
Presenter(s):Philip P. Goodney, MD, MS Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
1:48 PM - 1:54 PM | Panel Discussion |
END OF SESSION 43 | |
SESSION 44 SCHEDULE | |
Wednesday
SESSION 44:
MORE NEW DEVELOPMENTS RELATING TO AAAs AND EVAR
|
|
x | |
1:54 PM - 1:59 PM | The Gamesmanship And Subjectivity Involved In Measuring AAA Diameter: You Can Make It What You Want |
Presenter(s):Janet T. Powell, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
2:00 PM - 2:05 PM | Significance Of Infrarenal Aortas Measuring 25-29 mm In Diameter: They Will Likely Become Aneurysmal And They Require Follow-Up: At What Intervals |
Presenter(s):Martin Bjorck, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
2:06 PM - 2:11 PM | DEBATE: EVAR With Large Diameter Devices (Up To 36 mm) Can Be Effective And Are Associated With Acceptable Risks: Special Tips For Treatment |
Presenter(s):Michael J. Singh, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
2:12 PM - 2:17 PM | DEBATE: Not So. Large Diameter AAA Necks And Devices Over 28 mm Have Higher EVAR Failure Rates: How Should They Be Treated |
Presenter(s):Ali F. AbuRahma, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
2:18 PM - 2:23 PM | EVAR With Large Diameter Devices Have Increased Risks Of Failure: When Should Ch/EVAR Or F/EVAR Be Used Instead Of Standard EVAR With Large Diameter Devices |
Presenter(s):Jason T. Lee, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
2:24 PM - 2:29 PM | How And When To Treat Thrombus Within Endografts And The Native Aorta |
Presenter(s):Barend M.E. Mees, MD, PhD / Geert Willem H. Schurink, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
2:30 PM - 2:36 PM | Panel Discussion |
2:36 PM - 2:41 PM | Value And Limitations Of EVAR For Inflammatory AAAs And Other AAAs Of Rare Etiologies |
Presenter(s):Furuzan Numan, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
2:42 PM - 2:47 PM | How Best To Treat Inflammatory AAAs: When Is EVAR Best And When Is It Not |
Presenter(s):Sonia Ronchey, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
2:48 PM - 2:53 PM | What Is The Association Between AAAs, TBADs And Cancer: What Is It Due To |
Presenter(s):Natzi Sakalihasan, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
2:54 PM - 2:59 PM | Bare Stent Suprarenal Fixation For EVAR: Is It Harmful Or Beneficial: What Are The Pros And Cons |
Presenter(s):Claude Mialhe, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
3:00 PM - 3:05 PM | Fenestrated Iliac Limbs To Preserve Hypogastric Flow When IBDs Won’t Work: How To Obtain Them Or Make Them |
Presenter(s):Afshin Assadian, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
3:06 PM - 3:11 PM | Do We Have The Right Endograft To Treat AAAs In Women: What Is The Best Device For EVAR In Women: Should Open Repair Be Used More |
Presenter(s):Sigrid Nikol, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
3:12 PM - 3:17 PM | EVAR Explantation And Revascularization For Failure And Infection: Technical Tips And Results |
Presenter(s):Thomas C. Bower, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
3:18 PM - 3:23 PM | Panel Discussion |
3:24 PM - 3:30 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 44 | |
SESSION 45 SCHEDULE | |
Wednesday
SESSION 45:
CHALLENGING RECORDED LIVE CASES AND THOSE EMPLOYING INNOVATIVE TECHNIQUES
Location: Trianon Ballroom, 3rd Floor
Moderators:Plinio Rossi, MD / Andrew Holden, MBChB / Carlo Setacci, MD / Fabrizio Fanelli, MD, EBIR / Frank J. Veith, MD |
|
x | |
3:30 PM - 3:40 PM | Internal Iliac Artery Preservation Using Parallel Grafts: Successes And Mistakes |
Presenter(s):Andrew Holden, MBChB Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
3:40 PM - 3:50 PM | Hybrid Arterialization Of The Venous System Of The Foot In No Option CLI Patients |
Presenter(s):Roberto Ferraresi, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
3:50 PM - 4:00 PM | Complex TAAA Endovascular Repair |
Presenter(s):Stephan Haulon, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
4:00 PM - 4:10 PM | Retrograde BTK Micro-Stenting: Initial Experience |
Presenter(s):Marco G. Manzi, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
4:10 PM - 4:20 PM | TEVAR: Step-By-Step |
Presenter(s):Dittmar Boeckler, MD Location: Trianon Ballroom, 3rd Floor |
|
4:20 PM - 4:30 PM | Treatment Of A Type 3B Endoleak With Off-Label Use Of A Device Used In Structural Heart Disease |
Presenter(s):Jos C. van den Berg, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
4:30 PM - 4:40 PM | What Kind Of Drug Do We Need To Treat BTK Arteries In CLI Patients |
Presenter(s):Marianne Brodmann, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
END OF SESSION 45 | |
SESSION 46 SCHEDULE | |
Wednesday
SESSION 46:
RECORDED COMPLEX LIVE CASES FROM LEIPZIG AND LINC: PIONEERING TECHNIQUES FOR CHALLENGING VASCULAR PATHOLOGIES
|
|
x | |
4:40 PM - 5:00 PM | Minimal Invasive Segmental Artery Coil Embolization (MISACE) For Prevention Of Spinal Cord Ischemia During EVAR Of Thoracoabdominal Aortic Pathologies: Initial Clinical Results |
Presenter(s):Daniela Branzan, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
4:50 PM - 5:00 PM | Minimal Invasive Segmental Artery Coil Embolization (MISACE) For Prevention Of Spinal Cord Ischemia During EVAR Of Thoracoabdominal Aortic Pathologies: Initial Clinical Results: Technical Aspects |
Presenter(s):Andrej Schmidt, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
5:00 PM - 5:10 PM | Experience With A New Nano-Coated DCB: 12-Month Results From The EFFPAC-RCT |
Presenter(s):Marcus Thieme, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
5:10 PM - 5:20 PM | Recorded Case: Transluminal Tumescent Anesthesia During Angioplasty Of Severely Calcified Vessels |
Presenter(s):Andrej Schmidt, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
5:20 PM - 5:30 PM | DCB + Focal scaffolding: The New Concept For Optimized BTK Angioplasty? |
Presenter(s):Marianne Brodmann, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
5:30 PM - 5:40 PM | Recorded Case: DCB + Tack Scaffolds BTK |
Presenter(s):Andrej Schmidt, MD Location: Trianon Ballroom, 3rd Floor |
|
5:40 PM - 5:50 PM | Recorded Case: Prerecorded Percutaneous Deep Venous Arterialization: Procedure Using The LimFlow Technique |
Presenter(s):Steven Kum, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
END OF SESSION 46 |